$DREM
Dream Homes & Development Corp. Stock $drem

$drem Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224041166 Filed on October 15, 2024

Income Statement

Concept	2024 Q4	2024 Q1	2023 Q1
Revenue		$1.474M	$1.104M
YoY Change		33.43%	10.98%
Cost Of Revenue		$1.240M	$651.4K
YoY Change		90.4%	11.38%
Gross Profit		$233.4K	$453.0K
YoY Change		-48.48%	10.4%
Gross Profit Margin		15.84%	41.02%
Selling, General & Admin		$331.7K	$295.4K
YoY Change		12.28%	36.76%
% of Gross Profit		142.11%	65.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$0.00	$1.575K
YoY Change		-100.0%	-6.8%
% of Gross Profit		0.0%	0.35%
Operating Expenses		$331.7K	$297.0K
YoY Change		11.69%	36.42%
Operating Profit		-$98.30K	$156.0K
YoY Change		-163.01%	-19.01%
Interest Expense		-$19.05K	$55.60K
YoY Change		-134.26%	-302.76%
% of Operating Profit			35.64%
Other Income/Expense, Net		-$19.05K	-$55.60K
YoY Change		-65.74%	102.75%
Pretax Income		-$117.4K	$100.4K
YoY Change		-216.87%	-39.22%
Income Tax
% Of Pretax Income
Net Earnings		-$122.6K	$100.4K
YoY Change		-222.11%	-39.22%
Net Earnings / Revenue		-8.32%	9.09%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	47.41M shares	46.26M shares	35.82M shares
Diluted Shares Outstanding		46.26M shares	35.82M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.452M	$191.1K
YoY Change	1182.93%	49.9%
Cash & Equivalents	$2.452M	$191.1K
Short-Term Investments
Other Short-Term Assets	$332.4K	$398.3K
YoY Change	-16.56%
Inventory
Prepaid Expenses
Receivables	$165.4K	$191.4K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.051M	$946.7K
YoY Change	222.31%	34.98%
LONG-TERM ASSETS
Property, Plant & Equipment		$4.641K
YoY Change		-70.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$895.00	$6.489M
YoY Change	-99.99%	-16.83%
Total Long-Term Assets	$6.906M	$6.494M
YoY Change	6.35%	-17.28%
TOTAL ASSETS
Total Short-Term Assets	$3.051M	$946.7K
Total Long-Term Assets	$6.906M	$6.494M
Total Assets	$9.958M	$7.441M
YoY Change	33.83%	-12.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$621.3K	$678.8K
YoY Change	-8.47%	71.81%
Accrued Expenses	$353.0K	$261.7K
YoY Change	34.9%	79.53%
Deferred Revenue	$171.4K	$41.61K
YoY Change	311.92%
Short-Term Debt	$606.2K	$2.766M
YoY Change	-78.09%	-27.32%
Long-Term Debt Due	$922.0K	$927.7K
YoY Change	-0.61%	1.59%
Total Short-Term Liabilities	$3.184M	$4.686M
YoY Change	-32.06%	-14.02%
LONG-TERM LIABILITIES
Long-Term Debt	$6.158M	$2.015M
YoY Change	205.61%	-17.79%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$6.158M	$2.015M
YoY Change	205.61%	-17.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.184M	$4.686M
Total Long-Term Liabilities	$6.158M	$2.015M
Total Liabilities	$9.342M	$6.701M
YoY Change	39.41%	-15.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.857M	-$1.537M
YoY Change	20.85%
Common Stock	$47.41K	$35.82K
YoY Change	32.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$615.6K	$739.3K
YoY Change
Total Liabilities & Shareholders Equity	$9.958M	$7.441M
YoY Change	33.83%	-12.99%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$122.6K	$100.4K
YoY Change	-222.11%	-39.22%
Depreciation, Depletion And Amortization	$0.00	$1.575K
YoY Change	-100.0%	-6.8%
Cash From Operating Activities	-$114.7K	-$260.7K
YoY Change	-55.99%	-616.44%
INVESTING ACTIVITIES
Capital Expenditures	$97.25K	$307.9K
YoY Change	-68.41%	-157.96%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$97.25K	-$307.9K
YoY Change	-68.41%	-42.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$48.71K	$234.3K
YoY Change	-120.79%	-43.78%
NET CHANGE
Cash From Operating Activities	-$114.7K	-$260.7K
Cash From Investing Activities	-$97.25K	-$307.9K
Cash From Financing Activities	-$48.71K	$234.3K
Net Change In Cash	-$260.7K	-$334.3K
YoY Change	-22.01%	422.79%
FREE CASH FLOW
Cash From Operating Activities	-$114.7K	-$260.7K
Capital Expenditures	$97.25K	$307.9K
Free Cash Flow	-$212.0K	-$568.6K
YoY Change	-62.72%	-197.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	615647	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Depreciation Depreciation		usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Depreciation Depreciation		usd
CY2024Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale		usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit		usd
CY2024Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2024Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt		usd
CY2024Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q1	us-gaap	Depreciation Depreciation		usd
CY2024Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent		usd
CY2023Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent		usd
CY2023Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2024Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		usd
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		usd
CY2024Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2200	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2200	usd
CY2024Q1	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6903180	usd
CY2023Q4	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6805932	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	895	usd
CY2024Q1	us-gaap	Assets Assets	9957640	usd
CY2023Q4	us-gaap	Assets Assets	10108509	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	621335	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	537972	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	353012	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	354722	usd
CY2024Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	510000	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	510000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	171408	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	232603	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	180506	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	236703	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	921960	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	921960	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3183928	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3317179	usd
CY2024Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	6158065	usd
CY2023Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	6158065	usd
CY2024Q1	us-gaap	Liabilities Liabilities	9341993	usd
CY2023Q4	us-gaap	Liabilities Liabilities	9475244	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47414493	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40414493	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	47414	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	40414	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2425330	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2327330	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1857097	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1734479	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	615647	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	633265	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9957640	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10108509	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1473735	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1104466	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1240320	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	651444	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	233415	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	453022	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	331717	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	295434	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	331717	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	297009	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-98302	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	156013	usd
CY2024Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	19050	usd
CY2023Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	55597	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19050	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55597	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-117352	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	100416	usd
CY2024Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5266	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-122618	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46260647	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46260647	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35824493	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35824493	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	638844	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	739260	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	633265	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	633265	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	105000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-122618	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	615647	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-122618	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	100416	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-37104	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21609	usd
CY2023Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	398304	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	48792	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-90646	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	895	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	81653	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	138502	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-61195	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-215145	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-114743	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-260701	usd
CY2024Q1	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	97248	usd
CY2023Q1	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	307883	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97248	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-307883	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	19000	usd
CY2023Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	1350000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	19050	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	544965	usd
CY2023Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	1725000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	32871	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	177702	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	64142	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	196500	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	75247	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	25383	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-48709	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	234309	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-260700	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-334275	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2712503	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	525389	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2451803	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	191114	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	105000	usd
CY2009Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	75000000	shares
CY2009Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2009Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2009Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2009Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zsBdiuGclKo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65887	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65887	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1575	usd
CY2024Q1	DREM	Other Deposits Net OtherDepositsNet	4502619	usd
CY2023Q4	DREM	Other Deposits Net OtherDepositsNet	4413675	usd
CY2024Q1	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6903180	usd
CY2023Q4	DREM	Deposits And Costs Coincident To Acquisition Of Land For Development DepositsAndCostsCoincidentToAcquisitionOfLandForDevelopment	6805932	usd
CY2024Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	6158065	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	6158065	usd
CY2024Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	6158065	usd
CY2023Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	6158065	usd
CY2024Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2024Q1	us-gaap	Other Notes Payable OtherNotesPayable	180506	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	236703	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-25750	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21087	usd
CY2024Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5266	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20484	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-21087	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	950990	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	908660	usd

Files In Submission

Name	View Source	Status
0001493152-24-041166-index-headers.html	Edgar Link	pending
0001493152-24-041166-index.html	Edgar Link	pending
0001493152-24-041166.txt	Edgar Link	pending
0001493152-24-041166-xbrl.zip	Edgar Link	pending
drem-20240331.xsd	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
drem-20240331_def.xml	Edgar Link	unprocessable
drem-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
drem-20240331_cal.xml	Edgar Link	unprocessable
drem-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DREM
Dream Homes & Development Corp. Stock $drem

2024 Q4 Form 10-Q Financial Statement

#000149315224041166 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DREM Dream Homes & Development Corp. Stock $drem

2024 Q4 Form 10-Q Financial Statement

#000149315224041166 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DREM
Dream Homes & Development Corp. Stock $drem